Tubuloproteinuria in cancer chemotherapy.
D000419:Albuminuria; D000617:Aminoglycosides / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003404:Creatinine / Q000652:urine; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D007074:Immunoglobulin G / Q000652:urine; D007684:Kidney Tubules / Q000378:metabolism*; D011507:Proteinuria / Q000139:chemically induced*; D001613:beta 2-Microglobulin / Q000652:urine
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D007074:Immunoglobulin G; D001613:beta 2-Microglobulin; D003404:Creatinine